Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > New post on LinkedIn

<< Previous

Bullboard Posts

Next >>

Comment by Thao977on Nov 18, 2021 6:53pm

145 Views

Post# 34143295

RE:RE:RE:New post on LinkedIn

We saw 2 very optimist person. They call it possible cure for cancer

Richard Beliveau
In 35 years, he never saw something promising like it
For now, they didn't have surprise. Everything was like expected
It's a dream for a searcher
Fast track, very exceptionnal to have it
Sortilin was never investigated. We are the first

Paul L
Agreed with DR Beliveau
Big Challenge. Financing !! Will need a lot of money but once clinical data will come, money will follow
US investor saw something very interresting in pre-clinical data.
---
Nothing new but it's good publicity.

<< Previous

Bullboard Posts

Next >>

Bombardier shows off Challenger 3500 for customers in Italy